Navarro Belén, Car Julieta, Sequeira Gabriel, Kerzberg Eduardo Mario
Rheumatology Department, Ramos Mejia Hospital, Buenos Aires City, Argentina.
Rheumatol Int. 2025 Apr 26;45(5):126. doi: 10.1007/s00296-025-05885-5.
Despite growing female participation in the workforce, gender disparities persist across sectors. Little is known about how these manifest in academic rheumatology in Argentina. To analyze recently published rheumatology research by Argentine authors from a gender perspective. A bibliometric analysis was conducted on rheumatology publications from 2018 to 2022 in the Argentine Journal of Rheumatology (AJR) and PubMed-indexed journals that included at least one Argentine author. Argentine authors were classified by gender, and authorship roles (overall, first, and corresponding authors) were assessed, along with pharmaceutical industry conflicts of interest (COIs). Of 130 AJR articles (1183 Argentine authors), 61.8% were women. In 440 PubMed-indexed articles (1957 Argentine authors), 55.2% were women. Women were more frequently first authors in both AJR and PubMed (67.7% vs. 58.4%; p = 0.13), but less often corresponding authors in PubMed (44%) than in AJR (60%; p = 0.02). In AJR, female authors had a higher median number per article (3, Interquartile range or IQR 2-6) than male authors (2, IQR 1-4; p = 0.002). In PubMed, male authors showed slightly greater median participation (1, IQR 1-2 vs. 1, IQR 0-2; p = 0.02). In industry-sponsored studies, only 28.1% of authors were women. In COI-declaring publications, 71.0% listed only male disclosures; of 153 total reports, just 26.8% were by women. Although women are the majority in Argentine rheumatology research, they remain underrepresented in leadership roles and industry-funded studies. Continued monitoring of gender and COI data is needed.
尽管女性劳动力参与率不断提高，但各部门的性别差距依然存在。对于这些差距在阿根廷学术风湿病学领域如何体现，人们知之甚少。从性别角度分析阿根廷作者最近发表的风湿病学研究。对2018年至2022年发表在《阿根廷风湿病学杂志》（AJR）以及PubMed索引期刊上的风湿病学出版物进行了文献计量分析，这些出版物至少有一位阿根廷作者。阿根廷作者按性别分类，评估作者身份角色（总体、第一和通讯作者）以及制药行业利益冲突（COI）。在130篇AJR文章（1183位阿根廷作者）中，61.8%为女性。在440篇PubMed索引文章（1957位阿根廷作者）中，55.2%为女性。女性在AJR和PubMed中更常担任第一作者（67.7%对58.4%；p = 0.13），但在PubMed中担任通讯作者的比例（44%）低于AJR（60%；p = 0.02）。在AJR中，女性作者每篇文章的中位数人数更高（3，四分位间距或IQR为2 - 6），高于男性作者（2，IQR为1 - 4；p = 0.002）。在PubMed中，男性作者的中位数参与度略高（1，IQR为1 - 2对1，IQR为0 - 2；p = 0.02）。在行业资助的研究中，只有28.1%的作者为女性。在声明利益冲突的出版物中，71.0%仅列出男性披露；在总共153份报告中，只有26.8%是女性作者的。尽管女性在阿根廷风湿病学研究中占多数，但她们在领导角色和行业资助研究中的代表性仍然不足。需要持续监测性别和利益冲突数据。
